Inari Medical, Inc.
DelistedCIK 1531048fmd_1WWEKFX3EM5RF0EZ7K3VSCKBCTManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2024, 24 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Total revenues | 7 | 51 | 140 | 277 | 383 | 494 |
| Cost of revenue | 1 | 6 | 13 | 25 | 45 | 59 |
| Gross profit | 6 | 45 | 127 | 252 | 339 | 435 |
| Research and development | 4 | 7 | 18 | 51 | 74 | 88 |
| Selling, general and administrative | 11 | 37 | 90 | 190 | 293 | 361 |
| Total operating expenses | 15 | 44 | 108 | 241 | 367 | 449 |
| Operating income | (9) | 1 | 18 | 11 | (28) | (14) |
| Interest expense | 1 | 1 | 1 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 | 2 | 16 |
| Other non-operating income (expense) | (1) | (2) | (5) | (0) | 2 | 18 |
| Income before taxes | (10) | (1) | 14 | 11 | (26) | 4 |
| Income tax expense | 0 | 0 | 0 | 1 | 3 | 6 |
| Net income from continuing operations | (10) | (1) | 14 | 10 | (29) | (2) |
| Net income | (10) | (1) | 14 | 10 | (29) | (2) |